Vireo Growth

Vireo Growth, founded in 2014, is a prominent player in the pharmaceutical and healthcare sectors, specifically focusing on the medical cannabis industry. The company operates as a physician-founded entity dedicated to the end-to-end development, cultivation, manufacturing, distribution, and retail of cannabis-based products. By prioritizing scientific rigor, safety, and compassionate patient care, Vireo Growth has established itself as a pioneer in providing regulated medical cannabis solutions. The organization maintains a robust supply chain infrastructure that supports its mission to deliver high-quality, safe access to patients across its operational footprint.

The company currently maintains a workforce of 500-1,000 employees who manage complex operations across its primary location. Vireo Growth leverages its internal expertise to ensure that every stage of the product lifecycle meets stringent safety standards. Meet Vireo Growth's team to understand the leadership and scientific professionals driving these initiatives. The company’s operational model is designed to scale effectively within the evolving regulatory landscape of the medical cannabis market, ensuring consistent product quality and reliable distribution channels for its patient base.

Financially, Vireo Growth demonstrates significant market activity, reporting annual revenue of $511.7M. The company is publicly traded under the ticker OTC: VREOF, reflecting its ongoing commitment to transparency and growth within the healthcare sector. Investors and stakeholders can Explore financial highlights to review detailed metrics regarding the company's recent funding rounds, which include various debt and stock issuance activities. With a strategic focus on long-term sustainability and patient-centric innovation, Vireo Growth continues to navigate the complexities of the pharmaceutical industry.